We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 279

Intellectual property weekly abstracts bulletin
  • Borden Ladner Gervais LLP
  • Canada, USA
  • May 22 2013

The Supreme Court has dismissed Eli Lilly of Canada Inc.’s leave on the issue, as summarized by the Court, as to whether the creation by the Federal


Patent not eligible for listing: patent claiming one medicinal ingredient,but directed to a fixed-dose combination of medicines
  • Borden Ladner Gervais LLP
  • Canada
  • October 15 2014

This was an appeal from two decisions for three proceedings before Prothonotary Milczynski, in which she determined that a patent could not be listed


Court determines beneficial ownership of several patents as part of action for wrongful conduct
  • Borden Ladner Gervais LLP
  • Canada
  • October 15 2014

This was an action by the Plaintiff for relief arising from the allegedly wrongful conduct of the Defendant Li. The Plaintiff claimed that Li


Court of Appeal confirms that subsequent declaration of invalidity does not vary order of prohibition
  • Borden Ladner Gervais LLP
  • Canada
  • December 18 2013

The issue to be determined by the Court of Appeal in this appeal was whether an Order of prohibition in a proceeding pursuant to the Patented


Appeals dismissed from quantification of s. 8 damages
  • Borden Ladner Gervais LLP
  • Canada
  • April 4 2014

As discussed above, in May 2012, the Federal Court quantified damages owed to Apotex and Teva pursuant to s. 8 of the NOC Regulations. (Teva decision


Appeal of the re-examination board’s decision dismissed: three claims rejected
  • Borden Ladner Gervais LLP
  • Canada
  • April 4 2014

This was an appeal of a decision of a Re-Examination Board cancelling three claims of Newco Tank Corp.’s (“Newco”) Canadian Patent No. 2,421,384 (the


Pleadings amendment re s. 53 allowed trial judge to determine materiality of inventors names
  • Borden Ladner Gervais LLP
  • Canada
  • December 4 2014

Idenix brought a motion to amend its pleadings. The Prothonotary granted leave to make certain amendments, however denied leave to make certain


Court grants order adding inventor
  • Borden Ladner Gervais LLP
  • Canada
  • December 4 2014

The Applicant, Dr. Falk Pharma GMBH sought an order pursuant to s. 52 of the Patent Act to vary inventorship on a patent. The Application was


Decision of Re-Examination Board affirmed on standard of reasonableness
  • Borden Ladner Gervais LLP
  • Canada
  • March 11 2015

The Re-examination Board found the Claims of a patent obvious in light of prior art submitted by the person requesting re-examination. In so holding


New trial ordered and injunction set aside due to a refusal to allow an amendment to the Defence and Counterclaim
  • Borden Ladner Gervais LLP
  • Canada
  • November 3 2014

The Federal Court of Appeal has heard three related appeals from this proceeding in the Federal Court, and in the result, has sent the matter back